Dopamine D 3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D 3 receptor antagonist GR103691 with typical and atypical neuroleptics

By Hurley M.J.   Stubbs C.M.   Jenner P.   Marsden C.D.  

European Journal of Pharmacology, Vol. 318, Iss. 2, 1996-12 ,pp. : 283-293

Elsevier

Access to resources Recommend Favorite

Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics

By Juckel Georg   Schlagenhauf Florian   Koslowski Michael   Filonov Dimitri   Wüstenberg Torsten   Villringer Arno   Knutson Brian   Kienast Thorsten   Gallinat Jürgen   Wrase Jana   Heinz Andreas  

Psychopharmacology, Vol. 187, Iss. 2, 2006-08 ,pp. : 222-228

Springer Publishing Company

Access to resources Recommend Favorite

Olanzapine-induced Fos expression in the rat forebrain; cross-tolerance with haloperidol and clozapine

By Sebens J.B.   Koch T.   Ter Horst G.J.   Korf J.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists

By Cook D.F.   Wirtshafter D.  

European Journal of Pharmacology, Vol. 349, Iss. 1, 1998-05 ,pp. : 41-47

Elsevier

Access to resources Recommend Favorite

Lack of cross-tolerance between haloperidol and clozapine towards Fos-protein induction in rat forebrain regions

By Sebens J.B.   Koch T.   Korf J.  

European Journal of Pharmacology, Vol. 315, Iss. 3, 1996-11 ,pp. : 269-275

Elsevier

Access to resources Recommend Favorite